The official Team Kentucky source for information concerning COVID-19

branding

NEW CDC Quarantine Guidance Learn More

View Vaccine Information

Kentucky Healthcare Guidance

Healthcare Providers | Labs | Facilities

The COVID-19 response in Kentucky involves stakeholders at every level of the healthcare system. The following documents and links reflect the most current guidance for healthcare providers, laboratories and local public health.

COVID-19 Case Reporting

CDC/KDPH COVID-19 Case Report Form  

Note: The CDC/KDPH COVID-19 Case Report Form replaces the EPID 200 and CDC Case investigation form.

COVID-19 Lab Result Reporting Guidance Updated

Healthcare Provider Case Reporting Guidance Updated

Quarantine Guidance

Guidance for COVID-19 Quarantine for Vaccinated Persons 

 Guidance for COVID-19 Quarantine of Vaccinated Persons in the Healthcare Setting

KDPH Guidance

Dr. Stack Memo to HCP re: Vaccine 

New CDC Quarantine Guidelines 

CDC Guidance

Vaccine Provider Enrollment Letter - 11/2/2020

Vaccine Provider Enrollment Checklist

Vaccine Provider Enrollment Workflow

CMS CoVax Information and Resources

Vaccine Provider Enrollment

Please read the Vaccine Provider Enrollment Letter and Checklist prior to completing the registration.

REGISTER    
  • Pfizer has 2 hotlines available for vaccine questions that are staffed 8 am-11 pm EST, 7 days a week.
    •  General Product Questions: storage & handling, basic dilution and administration 877-829-2619.
    • Medical Information: efficacy, safety, stability, dosage, mechanism of action, and vaccine ingredients 800-438-1985.
      • § Pfizer’s Shipping and Handling hotline will be staffed 8 am-8pm EST, 5 days a week. Shipping and Maintaining the Cold-Chain: dry ice, ordering, vaccine quantities, obtaining diluent 800-666-7248.

Draft: Kentucky Vaccination Plan

CDC Vaccine Toolkit – For Healthcare Providers

Guidance for Healthcare Personnel for Work while in Quarantine or Isolation 

Contingency and Crisis Staffing Strategies for Healthcare Facilities

Exposure and Quarantine Process

Antigen Test Result Guidance

Decision Tree- Community Exposure

Aerosol Exposure Consensus Statement

Guidance on Critical Infrastructure - Essential Worker Terminology 

Determining Exposure for Contacts of a Positive HCW in the Healthcare Setting 

HCW Contact Exposure Decision Tree within the Healthcare Setting

Learn More about Battelle CCDS services. Letter from Dr. Stack      Time Sensitive

COVID-19 Testing Services Contract

Blanket Test Order July 9, 2020 

Lab Services Form To be completed by labs offering COVID-19 services. 

Guidance for Release from Isolation/Return to Work 

Complete Healthcare Reopening Orders

E-kit Order

COVID-19 PPE Request Fact Sheet 

Optimization of PPE  

CDC Guidance for Certifying COVID-19 Deaths 

Video Guidance for Certification of COVID-19 Deaths

Rehabilitative Services and COVID-19  

Controlled Substance Prescribing (KBML)  

Elective Healthcare Services  

Guidance for Acute Healthcare Facilities in response to COVID-19 

COVID-19 Health Advisory Update and Clinical Guidance 

Guideline for Conservation of Respiratory Protection Resources 

KDPH Division of Laboratory Services

Long Term Care Guidance

Guidance for Long-Term Care 

Guidance –POC-Ag-testing LTCFs New

Resources

COVID-19: Deaf and Hard of Hearing Communication Access Recommendations for the Hospital 

SAMHSA OTP Guidance: SAMHSA issued guidance allowing states with and without emergency declarations to allow Opioid Treatment Programs (OTPs) to provide 28 days of take-home medication to stable patients and 15 days of medication to less stable patients whom the OTP believes can responsibly manage this amount of medication.

SAMHSA 42 CFR Part 2 Guidance: SAMHSA issued guidance which allows providers to share patient SUD diagnosis information that would normally be protected under 42 CFR Part 2 in instances of a bona fide medical emergency. Usage of the medical emergency exception must be documented by providers.

CMS Guidance to Catastrophic Coverage Plans: CMS issued an FAQ clarifying that catastrophic coverage plans must include coverage of COVID-19 diagnosis and treatment under the Essential Health Benefits. CMS will waive enforcement actions against any such plan which provides COVID-19 services before patients pay the plan’s deductible, and encourages plans and states to provide such pre-deductible coverage.

Update and Interim Guidance on Outbreak of COVID-19

Evaluating and Reporting Persons Under Investigation

Interim Infection Prevention and Control - Cases Confirmed or Under Investigation in Healthcare Settings

Interim Risk Assessment and Public Health Management - Travel-related or community transmission cases

COVID-19 Risk Assessment and Public Health Management Decision Making Flow Chart

Healthcare Infection Prevention and Control FAQs for COVID-19

Frequently Asked Questions About Personal Protective Equipment

Strategies for Optimizing Supply of N95 Respirators

Information for Laboratories

Interim U.S. Guidance for Risk Assessment and Public Health Management of Healthcare Personnel with Potential Exposure in a Healthcare Setting to Patients with COVID-19

Interim Guidance for Implementing Home Care of People Not Requiring Hospitalization for 2019 Novel Coronavirus (2019-nCoV)

Medical Reserve Corps Recruitment

Become a volunteer- Learn More about Medical Reserve Corps (MRC) Sign up to volunteer here.

Centers for Disease Control and Prevention

Visit CDC.gov